| Literature DB >> 22093337 |
Emiliano Rodríguez-Sánchez1, Sara Mora-Simón, María C Patino-Alonso, Ricardo García-García, Alfonso Escribano-Hernández, Luis García-Ortiz, Ma Victoria Perea-Bartolomé, Manuel A Gómez-Marcos.
Abstract
BACKGROUND: Few data are available on the prevalence of cognitive impairment (CI) in Spain, and the existing information shows important variations depending on the geographical setting and the methodology employed. The aim of this study was to determine the prevalence of CI in individuals aged over 65 in an urban area, and to analyze its associated risk factors.Entities:
Mesh:
Year: 2011 PMID: 22093337 PMCID: PMC3226440 DOI: 10.1186/1471-2377-11-147
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1Flow chart of the DERIVA Study.
Distribution according to gender and different age ranks of interviewed and lost sample population.
| Female (N = 302) | Male (N = 178) | Total (N = 480) | ||||
|---|---|---|---|---|---|---|
| Mean (SD) | 76.64 (7.64) | 77.52(7.08) | 75.81 (6.73) | 76.61 (7.65) | 76.35 (7.33) | 77.15 (7.80) |
| 65-69 (%) | 21.3 | 17.6 | 20.74 | 19.4 | 21.1 | 18.3 |
| 70-74 (%) | 21.8 | 20.9 | 22.4 | 25.8 | 22.0 | 22.9 |
| 75-79 (%) | 20.4 | 25.3 | 27.6 | 21.0 | 22.9 | 23.5 |
| 80-84 (%) | 19.5 | 17.6 | 19.0 | 14.5 | 19.3 | 16.3 |
| ≥ 85 (%) | 17.1 | 17.1 | 10.3 | 19.3 | 14.7 | 19.0 |
| Total: N (%) | 211 (64.5%) | 91 (59.5%) | 116 (35.5%) | 62 (40.5%) | 327 (100%) | 153 (100%) |
Crude, age-adjusted, and age- and sex-adjusted prevalence of dementia and cognitive impairment (CI).
| Crude | Age-adjusteda | Age, sex ajusteda | No. individualsb | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 14/116 | 12,1 | 6,1 18,0 | 10,7 | 4,6-16,9 | |||||
| 48/211 | 22,7 | 17,1-28,4 | 19,1 | 12,9-25,2 | |||||
| 62/327 | 19,0 | 14,7-23,2 | 16,1 | 11,6-20,6 | 14,9 | 10,6-19,2 | 51 | 36-65 | |
| 9/69 | 13,0 | 5,1-21,0 | |||||||
| 8/72 | 11,1 | 3,9-18,4 | |||||||
| 9/75 | 12,0 | 4,6-19,4 | |||||||
| 15/63 | 23,8 | 13,3-34,3 | |||||||
| 21/48 | 43,8 | 29,7-57,8 | |||||||
| 10/116 | 8,6 | 3,5 - 13,7 | 8,1 | 2,5-13,6 | |||||
| 38/211 | 18,0 | 12,8 - 23,2 | 15,1 | 9,6-20,6 | |||||
| 48/327 | 14,7 | 10,8 - 18,5 | 11,4 | 7,5-15,4 | 11,6 | 7,7-15,5 | 39 | 26-53 | |
| 8/69 | 11,6 | 4,0-19,1 | |||||||
| 7/72 | 9,7 | 2,9-16,6 | |||||||
| 3/75 | 4,0 | 0,0-8,4 | |||||||
| 12/63 | 19,0 | 9,4-28,7 | |||||||
| 11/48 | 22,9 | 11,0-34,8 | |||||||
| 4/116 | 3,4 | 0,1 - 6,8 | 2,7 | 0,0 - 5,3 | |||||
| 10/211 | 4,7 | 1,9 - 7,6 | 4,0 | 1,3 - 6,8 | |||||
| 14/327 | 4,3 | 2,1 - 6,5 | 3,4 | 1,5 - 5,3 | 3,3 | 1,4 - 5,2 | 11 | 5-18 | |
| 1/69 | 1,4 | 0,0 - 4,3 | |||||||
| 1/72 | 1,4 | 0,0 - 4,1 | |||||||
| 6/75 | 8,0 | 1,9 - 14,1 | |||||||
| 3/63 | 4,8 | 0,0 - 10,0 | |||||||
| 3/48 | 6,3 | 0,0 - 13,1 | |||||||
Age standardization weights European Standard: 36.4, 27.3, 18.2, 9.1 and 9.1 for 65-69, 70-74, 75-79, 80-84 and ≥85, respectively; sex standardization weight: 0.50 (sources: http://www.wmpho.org.uk/localprofiles/metadata.aspx?id=META_EUROSTD) [26];
Estimated number of subjects in hundreds with de disease based on age- and sex-adjusted prevalence (Salamanca h ≥65 years 2009 estimated population: 34.020h. (source: Castilla and León Regional Health Service lists. CIND: cognitive impairment not dementia; CI, confidence interval; PE, prevalence point-estimate; PP, crude prevalence ratio (cases divided by population).
Figure 2Crude, age-adjusted and age- and sex-adjusted prevalence of CIND and dementia.
Sociodemographic, functional, clinical and neuropsychological characteristics of the participants according to cognitive impairment (CI).
| Healthy subjects | Subjects | p | |
|---|---|---|---|
| 265(81.0) | 62 (19.0) | ||
| 75.46 ± 6.83 | 80.15 ± 8.18 | <0.001 | |
| Male | 75.26 ± 6.52 | 80.00 ± 7.22 | 0.013 |
| Female | 75.58 ± 7.04 | 80.19 ± 8.50 | <0.001 |
| 0.018 | |||
| Male | 102 (87.90) | 14 (12.1) | |
| Female | 163 (77.30) | 48 (22.7) | |
| 8.77 ± 2.77 | 6.93 ± 2.81 | <0.001 | |
| <0.001 | |||
| Iliterate | 68 (66.0) | 35 (34.00) | |
| Primariy-Secondary education | 152 (87.90) | 21 (12.1) | |
| Higher education | 45 (91.8) | 4 (8.2) | |
| 0.137 | |||
| Housewife | 68 (74.70) | 23 (25.30) | |
| Full-time job | 174 (84.10) | 33 (15.90) | |
| Others | 8 (88.90) | 1 (11.1) | |
| 158 (86.30) | 25 (13.7) | 0.007 | |
| 2.41 ± 1.87 | 2.09 ± 1.99 | 0.265 | |
| 0.065 | |||
| Alone | 56 (90.30) | 6 (9.70) | |
| With one relative/friend | 149 (81.0) | 35 (19.00) | |
| With at least with 2 people | 47 (75.80) | 15 (24.20) | |
| With more than 2 people | 4 (57.10) | 3 (42.90) | |
| All preserved | 120 (45.30) | 14 (22.60) | |
| Needs help on one activity | 49 (18.10) | 10 (16.10) | |
| Needs help on bathing and other activity | 1 (0.40) | 1 (1.60) | |
| Needs help on 6 activities | 0 (0.00) | 2 (3.20) | |
| Needs help on at least 2 activities, but not classifiable on previous categories | 95 (35.80) | 35 (56.50) | |
| Depression | 30 (11.30) | 17 (27.40) | 0.001 |
| Insomnia | 41 (15.50) | 17 (27.40) | 0.027 |
| Taking medicine for depression | 28 (10.6) | 17 (27.40) | 0.001 |
| Taking medicine for insomnia | 38 (14.30) | 15 (24.20) | 0.058 |
| Hypertension | 119 (45.20) | 22 (35.50) | 0.163 |
| Dyslipidemia | 12 (4.50) | 5 (8.10) | 0.259 |
| Diabetes Mellitus | 47 (17.70) | 18 (29.90) | 0.045 |
| Charlson comorbidity Index (by age) | 3.90 ± 1.46 | 4.50 ± 1.23 | 0.004 |
| MMSE (0-30)# | 27.30 ± 2.05 | 19.12 ± 4.74 | <0.001 |
| MMSE | <0.001 | ||
| 0-13 | 0 (0.00) | 5 (8.10) | |
| 14-23 | 3 (1.10) | 43 (69.40) | |
| 24-28 | 162 (61.10) | 3 (4.80) | |
| >28 | 81 (30.60) | 0 (0.00) | |
| Benton temporal orientation test | 5.16 ± 15.96 | 38.00 ± 35.66 | <0.001 |
| Clock drawing test# | 5.97 ± 1.52 | 3.91 ± 2.35 | <0.001 |
| Category Fluency# | 15.90 ± 5.04 | 9.45 ± 4.75 | <0.001 |
| 7 Minute Screen (Total)# | 48.82 ± 14.48 | 67.38 ± 31.87 | <0.001 |
CI: cognitive impairment (CIND or dementia); MMSE: Minimental State Examination.
#: Mean ± Standard deviation
p: Statistically significant differences between the two groups
MMSE: Mini-Mental State Examination score.
Figure 3Prevalence of CIND, CI or dementia according to level of studies, the features functional, clinical and neuropsychological participants.
Variables associated with presenting cognitive impairment (CI): OR and 95 confidence intervals for total CIND/dementia vs. Controls/Healthy.
| B | OR (95% CI) | P | |
|---|---|---|---|
| Age | 0.07 | 1.08 (1.03-1.12) | 0.00 |
| Gender | 0.58 | 1.79 (0.88-3.64) | 0.11 |
| Years of education | -0.24 | 0.79 (0.70-0.90) | 0.00 |
| Depression-anxiety | 1.25 | 3.47 (1.61-7.51) | 0.00 |
| Diabetes | 0.73 | 2.07 (1.02-4.18) | 0.04 |